Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2023-04-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Muscle Oxidative Capacity Relationship With Muscular Endurance, Fatigue (Multiple Sclerosis).
NCT06083194
Muscle Architecture in Ankylosing Spondylitis
NCT06226792
Patient-Centered Assessment of Symptoms and Outcomes
NCT03952624
Reliability and Validity of the Taiwan-version of Multidimensional Fatigue Inventory and Fatigue Severity Scale
NCT02596139
A Longitudinal Study on Longstanding Complicated Fatigue
NCT04955587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a definite diagnosis of Relapsing Remitting MS by a neurologist,
* Expanded Disability Status Scale (EDSS) score between 1-5.5,
* To be stable in medical treatment,
* Being able to stand independently for at least 60 seconds without any assistive device,
* It is to be above 24 points according to the Mini-Mental State Examination (MMSE) evaluation.
Exclusion Criteria
* Having had an MS attack in the last 3 months,
* Being illiterate or unable to communicate in Turkish,
* Having an active infection,
* Being pregnant,
* Having an orthopedic problem or having a surgery that may affect the lower extremity,
* Having an additional neurological or circulatory disease that may cause balance disorder, a problem affecting the vision or vestibular tract, or a diagnosis of orthopedic surgery, rheumatological disease,
* To be included in the physiotherapy and rehabilitation program in the last 3 months.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gazi University
OTHER
Asli Demirtaş
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asli Demirtaş
Lecturer, MSc., PT.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İlke KESER, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Gazi University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gazi University
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gazi University (2023-157)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.